Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant
Annals of Pharmacotherapy · 2026
DOI: 10.1177/10600280251367427 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Artemis R Huntsman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Solid Organ Transplant Specialty Pharmacy, University of California Davis Medical Center, Sacramento, CA, USA. Hauptthemen laut MEDLINE: Dapsone, Kidney Transplantation, Urinary Tract Infections, Trimethoprim, Sulfamethoxazole Drug Combination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dapsone is an alternative prophylactic agent for opportunistic infection in kidney transplant recipients (KTRs) with sufficient glucose-6-phosphate dehydrogenase levels. Potential disadvantages include increased risk for anemia and urinary tract infection (UTI) with dapsone.
Objective
The objective of this study was to compare the risks of anemia and UTI in KTRs who received prophylaxis for opportunistic infection after renal transplant with dapsone versus sulfamethoxazole-trimethoprim (SMX-TMP).
Methods
This single-center, retrospective, cohort review was conducted at a large academic health system. Adult patients who received SMX-TMP or dapsone prophylaxis after renal transplant were included. The primary outcome was risk of acute anemia within 90 days of transplant. Secondary outcomes included the risk of UTI post-transplant. Log-rank test was used for time-to-event analysis for the primary outcome.
Results
A total of 153 patients were included in the analysis. Patients were more likely to experience acute anemia while on dapsone compared with SMX-TMP (hazard ratio = 2.13, 95% confidence interval = 1.04-4.38, P = 0.04). No differences were observed in the rates of blood transfusion (14.5% vs 18.4%, P = 0.52) or use of erythropoiesis-stimulating agents (40.2% vs 48.7%, P = 0.331) between SMX-TMP and dapsone groups, respectively. The prevalence of UTI was comparable between groups (23.4% vs 23.7%, P > 0.999). Conclusion and Relevance: The risk of anemia was twofold higher in KTRs who received dapsone compared with SMX-TMP but did not appear to affect the rates of erythropoiesis-stimulating agent use or blood transfusion. There was no difference in the risk of UTI. These findings may inform agent selection and monitoring of prophylaxis for opportunistic infection in KTRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Solid Organ Transplant Specialty Pharmacy, University of California Davis Medical Center, Sacramento, CA, USA.
- Primary Care, University of California Davis Medical Center, Sacramento, CA, USA.
- Infectious Disease and Solid Organ Transplant, University of California Davis Medical Center, Sacramento, CA, USA.
- Research and Outcomes, University of California Davis Medical Center, Sacramento, CA, USA.
- University of California San Francisco School of Pharmacy, Sacramento, CA, USA.
ORCID-Profile: Artemis R Huntsman, Christian J Squires, Jeremiah J Duby
Zitieren
APA
Huntsman, A. R., Squires, C. J., Dray Vongspanich, J., & Duby, J. J. (2026). Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251367427
Vancouver
Huntsman AR, Squires CJ, Dray Vongspanich J, Duby JJ. Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280251367427
BibTeX
@article{Huntsman2026,
author = {Huntsman, Artemis R and Squires, Christian J and Dray Vongspanich, Joy and Duby, Jeremiah J},
title = {Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant},
journal = {Annals of Pharmacotherapy},
year = {2026},
doi = {10.1177/10600280251367427}
}
EUVIMED